Suzie Feeds The Bunny Osteomyelitis
Suzie Feeds The Bunny Osteomyelitis
Suzie Feeds The Bunny Osteomyelitis
X-ray results
On Suzies x-ray on the dorsal aspect of the metaphysis of the distal
phalanx there appears to be an osteolytic area. Some epiphyseal cartilage
destruction with an infused epiphysis is noted. It is difficult to assess,
however there may be the beginnings of a Brodies abscess. Regional
osteopenia is noted with adjacent soft tissue swelling visible. The dorsal
metaphysis appears hypo-lucent with moth-eaten or faded margins (Voit et.
Al, 2015).
Osteomyelitis
Prevention of Osteomyelitis
Suzies osteomyelitic infection could have been prevented if her
mother had brought her to the doctor after the event for prophylactic
antibiotic treatment. It is understandable for the delay in care since Suzie
was not in any distress and did not inform her mother that the injury was a
result of an animal bite. Good hygiene is a necessity to keep the wound
clean, which her mother did clean the site with soap and water and apply a
topical triple antibiotic cream and bandage. Suzie should wash her hands
several times daily with soap and water and keep the wound loosely dressed
with a gauze bandage (Rao, Ziran, & Lipsky, 2011).
MRI Reasoning
Suzie was given an MRI of her arms and legs to rule out further
involvement of the osteomyelitis into the long bones. Since osteomyelitis is
most common in the long bones in children she is considered high risk for
further development. It is also paramount that she gets fully treated so as
not to affect her growth plates, stunting her growth (Voit et, al, 2015).
Causes of Osteomyelitis
Osteomyelitis can be caused by a number of factors. Traumatic
penetrative injury, bloodstream infections, or local area infection can all be
factors in the development of osteomyelitis. Staphylococcus is the most
common infection to cause osteomyelitis, however, other bacteria and
fungal infections may also cause it. People with diabetes mellitus,
peripheral neuropathy, or peripheral vascular disease are at a higher risk of
developing osteomyelitis. Conditions or patients taking medications that
weaken their immune system are at a higher risk of developing
osteomyelitis as well. Risk factors include cancer, chronic steroid use, sickle
cell disease, human immunodeficiency virus (HIV), diabetes, hemodialysis,
intravenous drug users, infants, and the elderly (Rao, Ziran, & Lipsky,
2011).
Osteomyelitis Treatment
Treatment for acute osteomyelitis normally requires and
irrigation and drainage if there is an abscess, along with a culture to specify
the most sensitive antibiotic. If bone needs to be removed, it may need to be
replaced with bone graft or stabilized during surgery. In some instances, the
patient may need to wear a brace for stabilization. If bone needs to be
removed due to excessive damage or osteonecrosis during surgery, a bone
graft may also be necessary. In most cases treatment is effective with
antibiotics and pain medication. The duration of treatment of osteomyelitis
with antibiotics is usually four to eight weeks but varies with the type of
infection and the response to the treatments. The antibiotics normally need
to be intravenous, so the patient will normally also require a PICC line
insertion for the long term antibiotics and they can be taught to administer
their own medications in the comfort of their own home. In some cases the
use of a hyperbaric chamber may prove effective as well in treatment. The
hyperbaric chamber will help promote healing by increasing oxygenation to
the affected tissues, helping them heal faster (Rao, Ziran, & Lipsky, 2011).
7
References
Aneziokoro, C. O., Cannon, J. P., Pachucki, C. T., & Lentino, J. R. (2013). The
effectiveness and safety of oral linezolid for the primary and
secondary treatment of osteomyelitis.
Belthur, M. V., Birchansky, S. B., Verdugo, A. A., Mason, E. O., Hulten, K. G.,
Kaplan, S. L., ... & Weinberg, J. (2012). Pathologic fractures in
children with acute Staphylococcus aureus osteomyelitis. The Journal
of Bone & Joint Surgery, 94(1), 34-42.
Byren, I., Rege, S., Campanaro, E., Yankelev, S., Anastasiou, D., Kuropatkin,
G., & Evans, R. (2012). Randomized controlled trial of the safety and
efficacy of daptomycin versus standard-of-care therapy for
management of patients with osteomyelitis associated with prosthetic
devices undergoing two-stage revision arthroplasty. Antimicrobial
agents and chemotherapy, 56(11), 5626-5632.
Demirev, A., Weijers, R., Geurts, J., Mottaghy, F., Walenkamp, G., & Brans, B.
(2014). Comparison of [18 F] FDG PET/CT and MRI in the diagnosis of
active osteomyelitis. Skeletal radiology, 43(5), 665-672.
Ferguson, P. J., & Sandu, M. (2012). Current understanding of the
pathogenesis and management of chronic recurrent multifocal
osteomyelitis. Current rheumatology reports, 14(2), 130-141.
Kluin, O. S., van der Mei, H. C., Busscher, H. J., & Neut, D. (2013).
Biodegradable vs non-biodegradable antibiotic delivery devices in the
treatment of osteomyelitis. Expert opinion on drug delivery, 10(3),
341-351.
Kremers, H. M., Nwojo, M. E., Ransom, J. E., Wood-Wentz, C. M., Melton, L.
J., & Huddleston, P. M. (2015). Trends in the Epidemiology of
Osteomyelitis. The Journal of Bone & Joint Surgery, 97(10), 837-845.
Rao, N., Ziran, B. H., & Lipsky, B. A. (2011). Treating osteomyelitis:
antibiotics and surgery. Plastic and reconstructive surgery, 127, 177S187S.
Walter, G., Kemmerer, M., Kappler, C., & Hoffmann, R. (2012). Treatment
algorithms for chronic osteomyelitis. Deutsches rzteblatt
international, 109(14), 257.
Voit, A. M., Arnoldi, A. P., Douis, H., Bleisteiner, F., Jansson, M. K., Reiser, M.
F., & Jansson, A. F. (2015). Whole-body Magnetic Resonance Imaging
in Chronic Recurrent Multifocal Osteomyelitis: Clinical Long term
Assessment May Underestimate Activity. The Journal of rheumatology,
jrheum-141026.